Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer

Figure 8

(a–b) The correlation of immunocyte infiltration fraction with risk score. (c–e) PDCD1, LAG3, and CTLA4 expressed levels in high- and low-risk groups. (f–m) The abilities of the risk model to predict drug sensitivity: carboplatin, cisplatin, gefitinib, imatinib, dasatinib, erlotinib, oxaliplatin, and AZD6244. represents , represents , represents , and ns represents not significant.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)